| http://www.w3.org/ns/prov#value | - Based on available evidence, on August 5, the FDA panel approved [18F]FDG for use in diagnosing cardiovascular disease, tumors, and foci of epileptic seizures in the brain. [18F]FDG is a glucose analog, a chemical mimic of glucose, the body's prime energy source.
|
